Step 2: Reconstitute Using Slow-Wall Injection Technique to Prevent Protein Denaturation This is where most protocols fail
pRTECs that undergo ferroptosis may initiate a chain reaction that reduces the antioxidant capacity of surrounding cells, which in turn leads to oxidative damage to the renal tubules, furtherly promoting crystal aggregation and adhesion
Phase II clinical trials for inflammatory bowel disease reported no toxicity or adverse events in treated patients, though detailed safety data from these trials have not been published in peer-reviewed literature
doi: 10.3390/biomedicines8110454 22
Urrutia, S, Kantarjian, H, Ravandi-Kashani, F, Bueso-Ramos, CE, Kanagal-Shamanna, R, Jabbour, EJ, Montalban-Bravo, G, Short, NJ, Daver, N, Borthakur, G , DiNardo, CD, Kadia, TM, Masarova, L, Bose, P, Pemmaraju, N, Garcia-Manero, G, Sasaki, K